These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16885126)

  • 1. Controlled release by permeability alteration of cationic ammonio methacrylate copolymers using ionic interactions.
    Ravishankar H; Patil P; Samel A; Petereit HU; Lizio R
    Drug Dev Ind Pharm; 2006 Jul; 32(6):709-18. PubMed ID: 16885126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chloride ion exchange on the permeability and drug release of Eudragit RS 30 D films.
    Wagner K; McGinity J
    J Control Release; 2002 Aug; 82(2-3):385-97. PubMed ID: 12175751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gradation of microcapsule wall porosity by deposition of polymer mixtures (Eudragit RL and Eudragit RS). Phase separation of polymer mixtures and effects of external media and conditions on release.
    Donbrow M; Hoffman A; Benita S
    J Microencapsul; 1995; 12(3):273-85. PubMed ID: 7650592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of proteins to minimize the physical aging of EUDRAGIT sustained release films.
    Kucera SA; McGinity JW; Zheng W; Shah NH; Malick AW; Infeld MH
    Drug Dev Ind Pharm; 2007 Jul; 33(7):717-26. PubMed ID: 17654020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
    Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
    Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
    Kibria G; Islam KM; Jalil RU
    Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D.
    Bodmeier R; Guo X; Sarabia RE; Skultety PF
    Pharm Res; 1996 Jan; 13(1):52-6. PubMed ID: 8668678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid.
    Narisawa S; Nagata M; Hirakawa Y; Kobayashi M; Yoshino H
    J Pharm Sci; 1996 Feb; 85(2):184-8. PubMed ID: 8683446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms.
    Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    Pharm Res; 2005 Jul; 22(7):1129-41. PubMed ID: 16028014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
    Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
    Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of surfactants and additives on drug release from a cationic eudragit coated multiparticulate diltiazem formulation.
    Heinicke G; Schwartz JB
    Pharm Dev Technol; 2007; 12(4):381-9. PubMed ID: 17763143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anion-induced water flux as drug release mechanism through cationic Eudragit RS 30D film coatings.
    Wagner KG; Gruetzmann R
    AAPS J; 2005 Oct; 7(3):E668-77. PubMed ID: 16353943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
    Wulff R; Leopold CS
    Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of EUDRAGIT® RS on the release behaviour of theophylline solid dispersions].
    Orugun O; Oyi A; Olowosulu A; Apeji Y; Olayemi O
    Ceska Slov Farm; 2016; 65(6):226-231. PubMed ID: 28079388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.